Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sun Ten Phytotech is a Taiwan-based biopharmaceutical company dedicated to the development of botanical drugs through the modernization of traditional Chinese medicine. As the research and development arm of the Sun Ten Group, the company applies rigorous scientific methodologies and standardized manufacturing processes to create evidence-based herbal therapies. Their pipeline primarily targets oncology-related side effects, respiratory conditions, and chronic inflammatory diseases, with several candidates in Phase 2 clinical trials. The company utilizes a proprietary platform for botanical fingerprinting and quality control to ensure the consistency and safety of complex plant-derived mixtures. Sun Ten Phytotech maintains strategic collaborations with international academic institutions to validate the therapeutic potential of their phytomedicines. Their mission is to bridge the gap between traditional herbal knowledge and modern clinical requirements for global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sun Ten Phytotech.